SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-09-000705
Filing Date
2009-01-06
Accepted
2009-01-06 15:20:13
Documents
1
Period of Report
2008-12-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 28191
  Complete submission text file 0001127602-09-000705.txt   29989
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 205-444-4600
Babu Yarlagadda S (Reporting) CIK: 0001452635 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 09509778